News Owkin launches ATLANTIS patient data mining project Owkin has partnered 20 healthcare institutions on a patient data mining project, ATLANTIS, across oncology, immunology/inflammation, and neurology.
News AI tool detects brain lesions linked to epilepsy Researchers developed an artificial intelligence-powered tool that was able to detect two-thirds of epilepsy brain lesions missed by radiologists.
News Bill would allow AIs to prescribe FDA-approved drugs A US lawmaker has introduced a bill that would allow As to be qualified as health practitioners able to prescribe medicines.
News Ex-DeepMind scientist launches drug discovery company Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.
News Industry steps up as EU debates an action plan for AI Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.
News NHS trial puts AI for breast cancer screening under scrutiny Nearly 700,000 women will be recruited into an NHS trial of AI tools for breast cancer screening, in the hope of relieving pressure on radiologists.
Oncology On the forefront of healthcare change, turning innovative sc... Claus Zieler, chief commercial and medical affairs officer & member of the Executive Committee at Astellas Pharma, spoke with pharmaphorum at ASCO25.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face